Evidence map›Paper›PMID 20303366›Full record

ArticleBiochimica et biophysica acta2010

ErbB4 regulates the timely progression of late fetal lung development.

Washa Liu, Erkhembulgan Purevdorj, Katja Zscheppang, Dietlinde von Mayersbach, Jan Behrens, Maria-Jantje Brinkhaus, Heber C Nielsen, Andreas Schmiedl, Christiane E L Dammann

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Neuregulin-ErbB4 signaling in the developing lung alveolus: a brief review.Journal of cell communication and signaling · 2014
    Article
  16. Article
  17. TACE in perinatal mouse lung epithelial cells promotes lung saccular formation.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Washa LiuDivision of Newborn Medicine, Floating Hospital for Children at Tufts Medical Center, Boston, MA 02111, USA.
Erkhembulgan Purevdorj
Katja Zscheppang
Dietlinde von Mayersbach
Jan Behrens
Maria-Jantje Brinkhaus
Heber C Nielsen
Andreas Schmiedl
Christiane E L Dammann
Medizinische Hochschule Hannover · DETufts Medical Center · US

Funding

How Dose Androgen Inhibit Fetal MaturationR01HL037930 · NHLBI · TUFTS MEDICAL CENTER · PI NIELSEN, HEBER C. · 1986 to 2010
$3.0M
ErbB Signaling in Fetal Type II Cell GrowthR01HL085648 · NHLBI · TUFTS MEDICAL CENTER · PI DAMMANN, CHRISTIANE E, NIELSEN, HEBER C. · 2009 to 2012
$1.6M
NEUREGULINS AND THEIR RECEPTORS IN LUNG DEVELOPMENTK08HL004436 · NHLBI · TUFTS MEDICAL CENTER · PI DAMMANN, CHRISTIANE E · 2001 to 2005
$649k
NHLBI NIH HHS HL-037930NHLBI NIH HHS HL-04436NHLBI NIH HHS K08 HL004436NHLBI NIH HHS R01 HL037930NHLBI NIH HHS R01 HL085648
6 · The paper itself

Abstract

The ErbB4 receptor has an important function in fetal lung maturation. Deletion of ErbB4 leads to alveolar hypoplasia and hyperreactive airways similar to the changes in bronchopulmonary dysplasia (BPD). BPD is a chronic pulmonary disorder affecting premature infants as a consequence of lung immaturity, lung damage, and abnormal repair. We hypothesized that proper ErbB4 function is needed for the timely progression of fetal lung development. An ErbB4 transgenic cardiac rescue mouse model was used to study the effect of ErbB4 deletion on fetal lung structure, surfactant protein (SP) expression, and synthesis, and inflammation. Morphometric analyses revealed a delayed structural development with a significant decrease in saccular size at E18 and more pronounced changes at E17, keeping these lungs in the canalicular stage. SP-B mRNA expression was significantly down regulated at E17 with a subsequent decrease in SP-B protein expression at E18. SP-D protein expression was significantly decreased at E18. Surfactant phospholipid synthesis was significantly decreased on both days, and secretion was down regulated at E18. We conclude that pulmonary ErbB4 deletion results in a structural and functional delay in fetal lung development, indicating a crucial regulatory role of ErbB4 in the timely progression of fetal lung development.

Indexed as

AnimalsBronchopulmonary DysplasiaCD11b AntigenCells, CulturedErbB ReceptorsFemaleFetusFibroblastsHeartHumansInfant, NewbornMiceMice, TransgenicPregnancyPulmonary SurfactantsReceptor, ErbB-4CD11b AntigenERBB4 protein, humanErbb4 protein, mouseErbB ReceptorsPulmonary SurfactantsReceptor, ErbB-4

Identifiers

PMID20303366
PMCPMC3971952
OpenAlexW2140028157

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.